Health authorities in the Democratic Republic of the Congo began administering Ebola vaccinations in Kisangani on Thursday, launching a targeted campaign in the capital of Tshopo Province to protect frontline responders. The initiative prioritizes healthcare workers, emergency response teams, and individuals with direct contact with confirmed patients as the country confronts its deadliest recorded Ebola outbreak. Health Minister Samuel-Roger Kamba confirmed that the government deployed an initial supply of the Ervebo vaccine under a compassionate-use framework across impacted eastern provinces to safeguard essential personnel and help disrupt viral transmission chains.
Official epidemiological data indicates that the ongoing outbreak has spread across six eastern provinces, including Ituri, North Kivu, South Kivu, Tshopo, Haut-Uele, and Bas-Uele. Public health figures published by the Ministry of Public Health and Prevention show that the country has recorded 5,713 confirmed cases and 2,744 deaths. The current overall case fatality rate among confirmed patients stands at approximately 48%.
The health crisis has prompted international agencies, including the World Health Organization, to assist local medical teams with logistics, laboratory testing, and vaccine distribution efforts. Authorities are administering the Ervebo vaccine under a compassionate-use framework while researchers observe its efficacy against the circulating viral strain in the region. DR Congo initiates Ebola vaccination efforts as health workers intensify ring-vaccination strategies around identified infection clusters to contain viral spread.
Health Ministry Focuses on Ervebo Doses for Kisangani Medical Staff
Operational challenges such as complex regional infrastructure, ongoing security issues, and high population movement across border districts hinder logistical efforts. Cold-chain networks have been established in Kisangani to ensure the vaccine remains at the required ultra-low temperatures before distribution to remote health zones. DR Congo has launched the Ebola vaccination campaign while civil defense and community health workers conduct outreach to bolster disease surveillance and reporting.
Epidemiologists from the Africa Centres for Disease Control and Prevention collaborate closely with local teams to monitor adverse reactions and assess immune responses among vaccinated individuals. Officials highlight that prompt clinical detection, combined with isolation procedures and supportive treatment, remains vital to enhancing patient survival chances. Additional vaccine shipments are planned to expand regional distribution across secondary health districts.
Authorities Reinforce Stringent Infection Control in Treatment Facilities
National response units are extending contact-tracing operations throughout urban and rural zones of the eastern region. Health centers are receiving PPE, diagnostic reagents, and therapeutic supplies to improve readiness. The government states that comprehensive public health measures will stay in place until viral transmission rates decrease consistently across all affected provinces.
Officials urge communities to cooperate fully with mobile vaccination teams and to follow established health guidelines. The aim is to increase immunization among high-risk groups, stabilizing infection rates in the coming weeks. Enhanced surveillance will continue at transportation hubs and border crossings to prevent further spread geographically.